Navigation Links
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
Date:12/3/2007

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for SGX523. This compound is an internally developed, orally-bioavailable, small molecule inhibitor of the cMET receptor tyrosine kinase. The Company expects to begin Phase I clinical trials of SGX523 for solid tumor cancer patients in early 2008.

"This IND submission is one quarter earlier than originally anticipated and represents a significant achievement for our organization," said Mike Grey, President and Chief Executive Officer of SGX Pharmaceuticals. "Submission of the SGX523 IND package less than ten months after the compound's nomination as a formal development candidate speaks highly of the effectiveness of our research and development capabilities. We look forward to capitalizing on this positive momentum and initiating clinical studies in solid tumor cancer patients following FDA review of our submission."

About SGX523 and cMET

SGX523 has shown significant selectivity for the cMET receptor tyrosine kinase over more than 200 protein kinases and has demonstrated both potent in vitro blockade of the activity of this cancer target and in vivo activity against human cancer cells that depend on cMET for their uncontrolled growth and proliferation. The cMET receptor tyrosine kinase has been implicated in a wide range of cancers, including both solid and blood tumors. cMET has been extensively studied in both the laboratory environment and the clinic, with increasing data suggesting that uncontrolled stimulation of cMET plays a key role in a variety of effects associated with cancer, inc
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... October 19, 2014 Mercy’s student mentoring ... report on programs that help college students succeed. ... software and services, published the recent paper, “Retention and ... and Mercy is one of six higher education institutions ... fall to fall retention rates for first-time, full-time students ...
(Date:10/18/2014)... (PRWEB) October 19, 2014 Recently, BamboofloorChina.com, one ... market, has added a new assortment of bamboo floorings ... offering huge price cuts for worldwide clients now, up to ... of useful and durable items for sale now; most of ... decades. Clients can find more than 100 different kinds of ...
(Date:10/18/2014)... October 2014 All humans have a natural opioid system ... ECNP Congress in Berlin, has found that the opioid ... normal healthy volunteers. The work was carried out by ... and was funded by the Medical Research Council. This ... Neuropsychopharmacology congress in Berlin., Gambling is a widespread behaviour ...
(Date:10/18/2014)... NY (PRWEB) October 18, 2014 Ticket Down is ... prices have eased considerably for this year's World Series. ... in the World Series this year. This determined team has ... The San Francisco Giants have had better luck in terms of ... 2010, 1954, 1933, 1922, 1921 and 1905. This team ...
(Date:10/18/2014)... 18, 2014 Market Research ... Industry, 2009-2019 is a professional and in-depth ... Chondroitin sulfate industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Chondroitin sulfate listing their product ...
Breaking Medicine News(10 mins):Health News:Mercy’s PACT Student Mentoring Program Recognized for Helping College Students Succeed 2Health News:Brand New Bamboo Floorings Now Unveiled By BamboofloorChina.com, A Distinguished Supplier In The Market 2Health News:Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers 2Health News:2014 World Series Tickets: Giants vs. Royals World Series Ticket Prices Have Eased Substantially 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 4
... 22 Val J. Halamandaris,President of the National Association ... Americans to commemorate the power of caring, both at ... National Home,Care and Hospice Month., "It is highly ... day to,celebrate the nurses, therapists, aides and other providers ...
... 22, 2007 The Autism Consortium, a group of ... and enhancing clinical care for autism, announced today that ... Spectrum Disorders (ASD) through its Autism Gene Discovery Project ... database that autism researchers around the world can use. ...
... 2007Four Mary Ann Liebert, Inc. journals are participating in ... a special worldwide publishing event on October 22, 2007 ... and human development. The Council of Science Editors has ... of key journals throughout the world, including those published ...
... giveaway, researcher says, , , MONDAY, Oct. 22 (HealthDay News) -- ... lung doctor says a common device can determine whether someone ... could be used to ferret out people who hide a ... also help show patients what smoking is doing to their ...
... (Chicago, IL, October 22, 2007) A new study shows ... vary with age. The study presented at CHEST 2007, the ... Chest Physicians (ACCP), found that smokers over age 65 reported ... a major health problem, while smokers under age 65 reported ...
... important advances toward a therapeutic device that has the ... blood stream and treat them. Among other applications, such ... tissues, or signal stem cells to differentiate. , Their ... cells down as they flow through blood vessels. As ...
Cached Medicine News:Health News:U.S. Celebrates National Home Care and Hospice Month in November 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 3Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 4Health News:Global theme issue on poverty and human development 2Health News:Blood Test Catches Secret Smokers 2Health News:Blood Test Catches Secret Smokers 3Health News:Age affects motivation for quitting smoking 2Health News:MIT works toward novel therapeutic device 2Health News:MIT works toward novel therapeutic device 3
(Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
(Date:10/17/2014)... NORWALK, Conn. , Oct. 17, 2014 UBM ... , a leading online community and information resource for ... Parkinson disease and Alzheimer disease , with discussions ... Up to 1 million Americans have Parkinson disease , ... muscular dystrophy, or Lou Gehrig disease. Diagnosis can ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
Digital Ultrasonic Diagnostic Imaging System...
...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Medicine Products: